Adagio Medical Holdings, Inc Common Stock (ADGM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Adagio Medical Holdings, Inc Common Stock (ADGM) has a cash flow conversion efficiency ratio of 12.675x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-5.26 Million) by net assets ($-415.00K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Adagio Medical Holdings, Inc Common Stoc worth for the company's overall valuation and market capitalisation.
Adagio Medical Holdings, Inc Common Stock - Cash Flow Conversion Efficiency Trend (2021–2025)
This chart illustrates how Adagio Medical Holdings, Inc Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Adagio Medical Holdings, Inc Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Adagio Medical Holdings, Inc Common Stock ranked by their cash flow conversion efficiency. Explore ADGM operating cash flow to net income to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Saray Matbaacilik Kagitcilik Kirtasiyecilik Ticaret ve Sanayi AS
IS:SAMAT
|
-0.082x |
|
GT Biopharma Inc
NASDAQ:GTBP
|
-0.326x |
|
Investsmart Group Ltd
AU:INV
|
0.282x |
|
Standard Industries Limited
NSE:SIL
|
0.540x |
|
Tan Dai Hung Plastic JSC
VN:TPC
|
N/A |
|
PATERSON RESOURCES LTD
F:U40
|
N/A |
|
NFL Biosciences SAS
PA:ALNFL
|
0.032x |
|
TwentyFour Income Fund Ltd
LSE:TFIF
|
0.015x |
Annual Cash Flow Conversion Efficiency for Adagio Medical Holdings, Inc Common Stock (2021–2025)
The table below shows the annual cash flow conversion efficiency of Adagio Medical Holdings, Inc Common Stock from 2021 to 2025. View ADGM stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $12.40 Million | $-19.01 Million | -1.533x | -3.63% |
| 2024-12-31 | $19.91 Million | $-29.46 Million | -1.479x | -27009.22% |
| 2023-12-31 | $-132.02 Million | $-725.86K | 0.005x | -97.65% |
| 2022-12-31 | $-95.88 Million | $-22.41 Million | 0.234x | -12.08% |
| 2021-12-31 | $-72.62 Million | $-19.31 Million | 0.266x | -- |
About Adagio Medical Holdings, Inc Common Stock
Adagio Medical Holdings, Inc., a medical technology company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature ablation (ULTA) catheter and system; vCLA… Read more